http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013201492-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
filingDate | 2013-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de9691cbd608af946064231166e9fd60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcdf2c9b0be6903d0c7d9f133b39dc09 |
publicationDate | 2013-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2013201492-A1 |
titleOfInvention | Esketamine for the treatment of treatment-refractory or treatment-resistant depression |
abstract | The present invention is directed to methods for the treatment of treatment-refractory depression or treatment-resistant depression comprising 5 administering to a patient in need thereof, a therapeutically effective amount of esketamine as mono-therapy or as combination therapy with at least on antidepressant. |
priorityDate | 2012-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 200.